Efficacy and safety of enzalutamide (ENZA) monotherapy in hormone-naive prostate cancer (HNPC).

Matthew Raymond Smith, Michael Borre, Per Rathenborg, Patrick Werbrouck , Hendrik von Poppel , Axel Heidenreich, Peter Iversen, Edwina Baskin-Bey, Frank Perabo, De Phung, Bertrand Tombai

Original languageEnglish
JournalJournal of Clinical Oncology
Volume31
Issue number15_suppl
Pages (from-to)5001
Number of pages1
ISSN0732-183X
Publication statusPublished - 2013
EventAmerican Society of Clinical Oncology, Annual Meeting - Chicago , United States
Duration: 31 May 20134 Jun 2013

Conference

ConferenceAmerican Society of Clinical Oncology, Annual Meeting
Country/TerritoryUnited States
CityChicago
Period31/05/201304/06/2013

Cite this